🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to further study the pharmacokinetic character...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2016-06
Trial ID
NCT02825563
Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Status
Completed
Location
Sixth People's Hospital of Luoyang
Start Date
2021-05-20
Trial ID
NCT04660097
There is no standard treatment for chondrosarcoma. Some small sample of stu...
Status
Unknown
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-02-06
Trial ID
NCT05193188
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of S1 combin...
Status
Completed
Location
Taizhou Hospital, Wenzhou Medical University
Start Date
2019-03-01
Trial ID
NCT03823118
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Status
Unknown
Location
Multiple Locations
Start Date
2018-11-30
Trial ID
NCT03750916
Treatments Being Tested
To evaluate the progression free survival of patients with extensive stage ...
Status
Unknown
Location
Cancer hospital Fudan University
Start Date
2019-04-01
Trial ID
NCT03841136
Treatments Being Tested
This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anl...
Status
Recruiting
Location
Jiangxi Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05252078
Treatments Being Tested
Research purposes: the research design in the late more than 2 lines TNBC p...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-12-06
Trial ID
NCT06878625
This study was designed to investigate the efficacy and side effects of com...
Status
Unknown
Location
Multiple Locations
Start Date
2019-04-01
Trial ID
NCT03890055
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229